Argenit Ranks Among World's First Four in Cancer Detection

Argenit Ranked Among World's Top Four in Cancer Detection Chromosome analysis is a market with nearly half a million tests conducted annually in Turkey, representing a transaction volume of USD 30 million. According to the 2025 Digital Pathology Market Report, the market size for digital pathology, one of the latest technologies used in cancer diagnosis, is expected to approximately double in 2025, reaching USD 992.1 million. Argenit enables early diagnosis and appropriate treatment determination for patients, improving treatment success rates. Argenit, which develops software with Turkish language support in its field, digitalizes laboratory data. The chromosome analysis system developed by Argenit has a 99.9% success rate in correctly identifying many genetic diseases ranging from Down syndrome to cancer.

Domestic Pride in a Billion-Dollar Market

Argenit, a domestic player in the chromosome analysis and digital pathology market with a total size approaching one billion dollars, produces diagnostic systems through artificial intelligence technology it has developed. Highlighting that artificial intelligence algorithms can recognize cancer cells similar to face recognition systems, Burak Buyrukbilen, one of Argenit's co-founders, said: "Our digital image analysis system, which reduces margin of error in diagnosis, stands out as a technology that increases success rates in treatment processes. We rank among the world's top four companies in cancer detection. Among our objectives is reducing import dependency through domestic and national products we provide to the healthcare sector. Our domestic solutions and use of our own resources in healthcare make Argenit distinctive through accessibility, cost-effectiveness, Turkish language support and 24/7 technical support." he said.